McGraw Hill MasterClass with Dr. Jason Ryan: Boosting Student Success Amid Declining Step 1 Pass Rates

 

REGISTRATION LINK: https://learn.mheducation.com/60770-IM_US-UME_WEBINAR_2-JUN_2024_WebinarLP.html

Thursday Webinar: Dr. Yoo on Skin Cancer Awareness for All Skin Types

UpToDate Lexidrug News and Enhancements – June 2024

 

 

 

UpToDate Lexidrug Updates

 

June 2024

 

 

At Wolters Kluwer, we are committed to continuous enhancements and innovations — in content, features, and technology. Check out the most recent UpToDate® Lexidrug™ updates, designed to help improve clarity in treatment decisions and answer your clinical questions quickly. Please feel free to share this newsletter with your colleagues! In this issue:  The UpToDate suite of solutions Tips and tricks: International Brand Names Internet Explorer 11 (IE11) retirement reminder Recent FDA approvals Wolters Kluwer Health in the news Over-the-counter (OTC) birth control pills: Improving access and reducing barriers

 

The UpToDate suite of solutions As a reminder, we have unified market-leading solutions Lexicomp® and Emmi® under the UpToDate brand to create a fully harmonized suite of offerings for health systems, and to support care teams and patients across the ecosystem. UpToDate® Lexidrug™, formerly Lexicomp, will continue to deliver the referential drug content you trust to make the best possible evidence-based medication decisions.

 

Read More

 

 

Tips and tricks: International Brand Names To help make it easier to verify medicines, accurately prescribe them, and improve patient safety, Lexidrug includes more than 500,000 international brand names from 150+ countries to its extensive international drug brand name database. An enhanced search functionality is available within the Brand Names: International field in Lexidrug monographs for easy access to the expanded list of international brand names.

 

Check it Out

 

 

Internet Explorer 11 (IE11) retirement reminder We will be making security enhancements to UpToDate® Lexidrug™ platforms consistent with the changes Microsoft has made to discontinue support of IE11. As of June 20, 2024, we have ended support of IE11 for Lexidrug. To ensure an optimal user experience, please transition to using a supported browser, including the latest versions of Edge, Chrome, Firefox, and Safari. Please contact your IT department if you need help with the transition to a new browser.

 

 

Stay updated on recently approved drugs Be sure to check out the "New FDA Drug Approvals" section on the Lexidrug homepage. Recent approvals include: Pneumococcal Conjugate Vaccine (21-Valent) New 06/18/24 Elafibranor New 06/11/24 Explore Full List

 

 

 

Wolters Kluwer Health in the news Forbes | How Enterprise Analytics Can Help Future-Proof Health Systems Greg Samios, President and CEO of the Clinical Effectiveness business at Wolters Kluwer, discusses "How Enterprise Analytics Can Help Future-Proof Health Systems" for Forbes.

 

Read More

 

Fierce Healthcare | Walmart's exit from health centers reflects broader challenges in primary care Chief Medical Officer, Dr. Peter Bonis shares his thoughts on the future of retail-based healthcare for Fierce Healthcare.

 

Read More

 

HIT Like a Girl Pod | Empowering Healthcare: A Dive into Clinical Decision Support Julie Frey, VP of Product Management, joins the HIT Like a Girl Pod to chat about Wolters Kluwer's role in healthcare, focusing on clinical decision support tools like UpToDate.

 

Read More

 

 

 

Over-the-counter (OTC) birth control pills: Improving access and reducing barriers Clinicians play a major role in helping patients understand the safety, availability, and benefits of OTC birth control—and the impact to contraception access is significant.

 

Learn More

 

 

Resources

 

Expert Insights Get deep domain expertise and information that accelerates decision making. Read More Help & Training Learn more about Lexidrug from our User Academy and Knowledge Base. See All Resources Lexidrug On-The-Go The Lexidrug mobile app is available for clinicians to download (at subscribing organizations). Learn More

HIMSS 2024 recap: Major announcements and latest innovations

 

 

 

HIMSS 2024 was an exciting conference this year as we unveiled our latest innovations, previewed solution concepts, and demoed the newest advancements Wolters Kluwer is making in clinical decision support, smart drug data, and engagement technology. Here are four ways Wolters Kluwer is addressing today’s pressing challenges in healthcare: Unification in today's healthcare landscape: The new UpToDate® solution suites include UpToDate, UpToDate Lexidrug™ (formerly Lexicomp®), and UpToDate Patient Engagement (formerly Emmi®) with the suites along with Medi-Span® provide consistent support across the care continuum. Learn more about the unified UpToDate suite in this brief video. AI Labs: Setting the standard for responsible point-of-care AI development with UpToDate; our approach to Clinical Generative AI prioritizes quality, reliability, and transparency. To learn more, watch this brief video about AI Labs. UpToDate Enterprise Edition launched during HIMSS 2024 to much fanfare. Learn more about how Wolters Kluwer is addressing the needs of modern healthcare systems with UpToDate Enterprise Edition. The value of analytics: We hosted an event on understanding the needs of modern health systems for better clinical decision-making. This session explored the power of clinician insights to help drive better health outcomes. Get more details in this recap of the conference.

Elevate Your Clinical Practice with Cultural Humility Webinar

We wanted to send a quick reminder about our upcoming webinar "Cultural Humility in Clinical Practice" sponsored by Lilly and featuring renowned experts Victoria Barbosa, MD and Justin Ko, MD, MBA. 

Date: Wednesday, November 15, 2023  
Time: 7:00 PM ET  
Location: Online - Join from Anywhere! 

Meet our presenters: 

• Dr. Barbosa is an Associate Professor of Dermatology at the University of Chicago where she also serves as Director of the Hair Loss Program and Director of Diversity, Equity, and Inclusion in the Section of Dermatology. 
• Dr. Ko is Chief of Medical Dermatology at Stanford and spearheads the dermatology department's efforts around digital health, quality, and value-based care. 

In this session, you'll: 

1. Self-assess your practice for areas of improvement with cultural humility. 
2. Discover how to enhance patient experiences and outcomes through cultural understanding. 
3. Learn practical, actionable methods for immediate application. 
4. Engage directly with our speakers in a dedicated Q&A session. 

Don't miss this opportunity to elevate your clinical practice and contribute to a more inclusive healthcare environment. Secure your spot now by clicking the button below: 

PS- Feel free to extend this invitation to your colleagues and friends who would benefit from this valuable webinar. 

We look forward to having you join us on November 15.  

Popular Derm Webinar NOW ON DEMAND

 

Our popular webinar, "FunDermentals: Important Principles in Dermatology" is now available on demand. Thanks to a collaboration with Vaseline, this master educational program explores the insights needed to improve your knowledge of skin conditions. Key info: Presenter: Steven Chen, MD, MS-HPEd, Assistant Professor of Dermatology, Harvard Medical School Focus: Skin anatomy, common conditions, skin of color, and skin cancer awareness Visual Aids: Clear explanations with images and diagrams *Exclusive Offer - All those who register for this webinar are entered into a raffle to win AirPods Pro! Don't miss this complimentary educational experience. Register and watch TODAY!

Upcoming live webinar: Drug Desensitization

UPCOMING LIVE WEBINAR Drug Desensitization: Mechanisms and Pharmacological Candidates Prof. Mariana C. Castells Harvard Medical School, USA

Drug allergy and hypersensitivity are growing health care concerns, which encompass a new discipline that is being led by allergists and clinical immunologists.

In the last 25 years, there has been an explosion in the number of new targeted drugs, such as monoclonal antibodies and small molecules, that address personalized diseases. These drugs have been used for the growing population that’s in need of curative treatments for cancer and improved quality of life for chronic, autoimmune, and inflammatory diseases. New symptoms and phenotypes have emerged with new therapies, and patient safety is compromised when they are re-exposed to first line treatments, which have induced a reaction.

Desensitization, a novel ground-breaking procedure that utilizes mast cell inhibitory mechanisms, is now available to safely provide first line therapies to patients with drug-induced hypersensitivity reactions.

Wednesday, November 15 5pm GMT (12pm EST)

REGISTER NOW

About the Speaker Mariana Castells, M.D., Ph.D. is a clinician-scientist with over 30 years of experience in allergy and immunology. She is a Professor of Medicine at Harvard Medical School with over 200 publications and Director of the Brigham and Women’s Mastocytosis Center – one of the few nationally and internationally recognized centers of excellence, which provides diagnosis, management, and treatment options for patients with mastocytosis and mast cell activation disorders. These are rare and potentially deadly disorders which are currently addressed using Tyrosine Kinase Inhibitors. Additionally, she is Director of the Drug Hypersensitivity and Desensitization Center at Brigham and Women’s and Dana Farber Cancer Institute, which for the last 20 years has provided over 900 high risk desensitization’s per year for patients with cancer, severe infections and inflammatory diseases, who are allergic to their first line therapy, thereby increasing their life expectancy and quality of life.

Webinar Sponsor: The Biomedical & Life Sciences Collection A collection used by universities, medical schools and global pharmaceutical companies in over 60 countries around the world. The collection contains over 3,000 specially commissioned seminar-style talks and interviews ranging from the fundamentals of life sciences to the latest developments in therapeutic interventions, from the level of the single molecule to entire populations. The content is arranged in subject areas and includes both advanced and introductory-level talks. New talks are published every month. The collection is ideal for faculty, post-docs, other researchers and both graduate and undergraduate students.

Looking for lectures on a specific topic?

VISIT THE COLLECTION

For further information contact HSTalks: Tel: +44 (0) 20 7092 3480, Email: access@hstalks.com Address: 40/41 Museum Street, London WC1A 1LT, United Kingdom